- Research works
- 56 ▲ 46% vs 2013–17
- Citations
- 1.4k 25.5 per fractional work
- Top-10% rate
- 11.8% record average 16.5%
- Open access
- 23% world 28%
Not ranked overall: Spectrum Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.
Which keywords describe research at Spectrum Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Immunotherapy, Targeted Therapy, Cancer Therapy, Cancer, Epigenetic Regulation and PET Imaging.
- Urothelial Carcinoma
- Metastatic Breast Cancer
- Trastuzumab
- Pharmacokinetics
- Metastatic
- Mucosal
- Chitosan
- Molecular Profiling
- Classification
- Genetic Mutations
- Drug Delivery
- EGFR Mutations
- Rituximab
- HDAC Inhibitors
- Nanoparticles
- Lymphoma
- PET Imaging
- Cancer Therapy
- Immunotherapy
- Clinical Trials
- Chemotherapy
- Cancer
- Targeted Therapy
- Epigenetic Regulation
- Genomic Profiling
- Treatment Guidelines
- Gene Expression
- Histone Deacetylases
- ALK Inhibitors
- Prognostic Factors
- Breast Cancer
- Prophylaxis
- Molecular Characterization
- Antimicrobial Agents
- Febrile Neutropenia
- Crystal Engineering
- Hematopoietic Stem Cells
- HER2
- Bladder Cancer
- Neoadjuvant Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 18×11 topics
- Clinical Trials5▲ 14×5 topics
- Cancer4▲ 5.3×11 topics
- Immunotherapy4▲ 11×11 topics
- Targeted Therapy4▲ 31×5 topics
- Cancer Therapy4▲ 10.0×6 topics
- Epigenetic Regulation3▲ 23×2 topics
- PET Imaging3▲ 23×3 topics
- Genomic Profiling3▲ 48×2 topics
- Lymphoma3▲ 33×3 topics
- Treatment Guidelines3▲ 23×2 topics
- Nanoparticles3▲ 3.5×4 topics
- Gene Expression2▲ 7.2×2 topics
- HDAC Inhibitors2▲ 227×1 topic
- Histone Deacetylases2▲ 227×1 topic
- Rituximab2▲ 29×2 topics
- ALK Inhibitors2▲ 75×1 topic
- EGFR Mutations2▲ 75×1 topic
- Prognostic Factors2▲ 9.2×7 topics
- Drug Delivery2▲ 8.1×2 topics
- Breast Cancer2▲ 14×4 topics
- Genetic Mutations2▲ 6.9×6 topics
- Prophylaxis2▲ 25×2 topics
- Classification2▲ 9.5×1 topic
- Molecular Characterization2▲ 18×3 topics
- Molecular Profiling2▲ 29×1 topic
- Antimicrobial Agents2▲ 178×1 topic
- Chitosan2▲ 59×1 topic
- Febrile Neutropenia2▲ 178×1 topic
- Mucosal2▲ 117×1 topic
- Crystal Engineering2▲ 26×2 topics
- Metastatic2▲ 49×2 topics
- Hematopoietic Stem Cells2▲ 28×2 topics
- Pharmacokinetics2▲ 10×3 topics
- HER22▲ 89×1 topic
- Trastuzumab2▲ 63×1 topic
- Bladder Cancer1▲ 65×1 topic
- Metastatic Breast Cancer1▲ 38×2 topics
- Neoadjuvant Therapy1▲ 11×2 topics
- Urothelial Carcinoma1▲ 55×1 topic
Which research topics does Spectrum Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Ethics in Clinical Research, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research and Nanoparticle-Based Drug Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ethics in Clinical Research Public Health, Environmental and Occupational Health 1 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 3 HER2/EGFR in Cancer Research Oncology 0 works
- 4 Nanoparticle-Based Drug Delivery Biomaterials 0 works
- 5 Immune cells in cancer Immunology 0 works
- 6 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
- 7 Cancer Genomics and Diagnostics Cancer Research 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 Pediatric Hepatobiliary Diseases and Treatments Surgery 0 works
- 10 Colorectal Cancer Treatments and Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Spectrum Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 46% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Henderson
- Roseman University of Health Sciences
- Cancer Research Foundation
- Green Valley High School
- Nevada State University
- St. Rose Dominican Hospital
- Orthopaedic Institute of Henderson
- K2 Energy Solutions (United States)
- Art Institute of Las Vegas
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.